Odensomab 60mg Injection is used in treating osteoporosis and reducing fracture risk by inhibiting osteoclast activity to increase bone density and strength. It belongs to the class of monoclonal antibody medicines.
It may also be prescribed for bone loss due to cancer treatments, high fracture risk in men and postmenopausal women, giant cell tumours, and cancer-related high calcium levels. Follow your doctor’s exact instructions for administration and inform them of any underlying conditions or medications. Report any side effects immediately and continue treatment for the prescribed duration.















